1. Real-world safety profile of eculizumab in patients with paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, or generalized myasthenia gravis: an integrated analysis of post-marketing surveillance in Japan

   • Jun-ichi Nishimura
   • Tatsuya Kawaguchi
   • Shoichi Maruyama

   Original Article 29 July 2023 Pages: 419 - 431

   

2. Lenalidomide treatment of Japanese patients with myelodysplastic syndromes with 5q deletion: a post-marketing surveillance study

   • Shuji Uno
   • Yoko Motegi
   • Yasuo Aoki

   Original Article Open access 26 July 2023 Pages: 432 - 442

   

3. A retrospective analysis of clinical features and treatment outcome in 21 patients with immunoglobulin M-related light-chain amyloidosis in Japan: a study from the Amyloidosis Research Committee

   • Shin-ichi Fuchida
   • Mizuki Ogura
   • Chihiro Shimazaki

   Original Article 29 July 2023 Pages: 443 - 449

   

4. Substitution of calcineurin inhibitors with corticosteroids after allogeneic hematopoietic cell transplantation

   • Shimpei Matsumi
   • Shun-ichi Kimura
   • Yoshinobu Kanda

   Original Article 22 July 2023 Pages: 450 - 461

   

5. Antibody response after third dose of COVID-19 mRNA vaccination in allogeneic hematopoietic stem cell transplant recipients is comparable to that in healthy counterparts

   • Erina Takagi
   • Seitaro Terakura
   • Hitoshi Kiyoi

   Original Article 10 August 2023 Pages: 462 - 471

   

6. A case of cold agglutinin syndrome associated with chronic lymphocytic leukaemia harbouring mutations in CARD11 and KMT2D

   • Masahiko Fukatsu
   • Yoichi Hamazaki
   • Takayuki Ikezoe

   Case Report 03 May 2023 Pages: 472 - 476

   

7. New onset of hypomegakaryocytic thrombocytopenia with the potential for progression to aplastic anemia after BNT162b2 mRNA COVID-19 vaccination

   • Mirei Kobayashi
   • Akio Mori
   • Takeshi Kondo

   Case Report Open access 23 May 2023 Pages: 477 - 482

   

8. Venetoclax with CAG regimen for early T-cell precursor acute lymphoblastic leukemia: a case report and literature review

   • Yihan Zhao
   • Shiqing Jiang
   • Lin Zhao

   Case Report 03 June 2023 Pages: 483 - 488

   

9. Mutated ZRSR2 and CUL3 accelerate clonal evolution and confer venetoclax resistance via RAS signaling pathway in blastic plasmacytoid dendritic cell neoplasm

   • Koichiro Fukuchi
   • Daisuke Koyama
   • Takayuki Ikezoe

   Case Report 08 April 2023 Pages: 489 - 493

   

10. Clinical and genetic features of Japanese cases of MDS associated with VEXAS syndrome

    • Hiroyoshi Kunimoto
    • Ayaka Miura
    • Hideaki Nakajima

    Case Report 17 April 2023 Pages: 494 - 502

    

11. Newly diagnosed extranodal NK/T-cell lymphoma, nasal type, at the injected left arm after BNT162b2 mRNA COVID-19 vaccination

    • Takuto Tachita
    • Takenori Takahata
    • Hirotake Sakuraba

    Case Report 24 April 2023 Pages: 503 - 507

    

12. Transcriptome sequencing identifies novel EVX fusions involved in transcriptional activation of HOX family genes in pediatric immature T-cell acute lymphoblastic leukemia: two cases reports and a literature review

    • Xiao Zhang
    • Bowen Cui
    • Shaoyan Hu

    Case Report 27 May 2023 Pages: 508 - 513

    

13. Acute monocytic leukemia with KMT2A::LASP1 developed 9 months after diagnosis of acute megakaryoblastic leukemia in a 2-year-old boy

    • Takashi Fujita
    • Hiroko Fukushima
    • Hidetoshi Takada

    Case Report 14 June 2023 Pages: 514 - 518

    

14. Successful treatment of DOCK8 deficiency by allogeneic hematopoietic cell transplantation from alternative donors

    • Asuka Kono
    • Manabu Wakamatsu
    • Hirokazu Kanegane

    Case Report 03 May 2023 Pages: 519 - 525

    

15. Measurable residual disease in Japanese patients with relapsed or refractory chronic lymphocytic leukemia treated with venetoclax

    • Koji Izutsu
    • Kazuhito Yamamoto
    • Dai Maruyama

    Letter to the Editor Open access 15 August 2023 Pages: 526 - 528